drugset / Trial / NCT07376200
Single-ascending Dose Study of HEC-151 Injection
RandomizedParallel-groupSingle-blindTreatment
Summary
Evaluate the safety, tolerability, PK/PD and immunogenicity characteristics of a single subcutaneous HEC-151 Injection solution in healthy participants
Timeline
- Start
- 2026-02-24
- Primary completion
- 2026-09-05
- Completion
- 2026-09-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HEC-151 | Unknown | — | Subcutaneous |
| Comparator | insulin degludec | Protein / enzyme biologic | — | Subcutaneous |
Indications
No indication recorded.